Even in patients with relatively common sinus disease, decision making about endoscopic sinus surgery (ESS) can be difficult, and not all cases are the same.
Tissue Engineering: New Treatment Possibilities for Otolaryngologists
A new era in efforts to treat patients with tissue loss or organ failure is under way, which has the potential to revolutionize the treatment of many diseases and conditions that otolaryngologists treat.
Microdebriders Offer New Surgical Options
Outpatient and Minimally Invasive Approaches Or Safe and Effective Options for Thyroid and Parathyroid Surgery
The Evolution of Endoscopic Sinus Surgery
Endoscopic sinus surgery was introduced into the United States more than 20 years ago; over that time period it has undergone significant changes, in terms of both surgical technique and our understanding of the disorder of chronic rhinosinusitis.
Evidence-Based Medicine Comes to Otolaryngology
Not long ago, physicians routinely decried evidence-based medicine (EBM) as an encroachment on their professional autonomy, a barrier to good patient care, insensitive to health care’s growing complexity, and at odds with the transcendent value of the physician-patient relationship.
Voice Therapy May Help Treat Vocal Fold Polyps and Cysts
Although voice therapy is commonly used as an initial treatment for vocal fold nodules, its role in the treatment of vocal fold polyps and cysts is less defined.
Staging and Treating Snoring and Obstructive Sleep Apnea
Obstructive sleep apnea (OSA) needs to be addressed as a multilevel disease, especially in patients who fail or can’t tolerate continuous positive airway pressure (CPAP).
Strategies for Improving FESS Outcomes
Although functional endoscopic sinus surgery (FESS) is a commonly used and well-established tool for the treatment of chronic rhinosinusitis, between 10% and 20% of patients will have recurrent disease and require further surgery.
Abbreviated Vaccine Treatment May Be an Effective Alternative to Three to Five Years of Allergy Shots
A regimen of six weekly shots of a novel vaccine may be an effective long-term approach for patients with allergic rhinitis, sparing them injections once or twice a week for three to five years, according to results of a pilot study published recently in the New England Journal of Medicine.
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- Next Page »